Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
France
(641/week)
Czechia
(265/week)
Poland
(200/week)
Italy
(197/week)
Germany
(162/week)
View all
(2,273/week)
News
United States
(477/week)
Manufacturing
(350/week)
Energy
(250/week)
Technology
(389/week)
Environment
(183/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Nucleosides
Aug 12, 2020
New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients
Jun 13, 2020
EHA25Virtual: A Paradigm Shift for the Treatment of Newly Diagnosed Older Acute Myeloid Leukemia Patients
Jun 13, 2020
VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients
May 14, 2020
Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS)
Mar 23, 2020
AbbVie Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA® (venetoclax) in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)
Jul 31, 2019
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
Mar 06, 2019
Inosine (CAS 58-63-9): Global Market Research Report, 2019 - ResearchAndMarkets.com
Dec 03, 2018
Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
Dec 02, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego
Nov 21, 2018
AbbVie Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Sep 19, 2018
Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting
Jul 09, 2018
Trovagene Presents Outlook for Second Half of 2018
Jun 27, 2018
Trovagene Announces Preliminary Clinical Data from First Dosing Cohort Demonstrating Durable Treatment Effect of PCM-075 in Combination with Cytarabine or Decitabine in Patients with Relapsed or Refractory AML
Jun 17, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm
Jun 15, 2018
Trovagene Announces Completion of First Dosing Cohort of Patients Treated with PCM-075 in Combination with Decitabine in Ongoing Phase 1b/2 AML Trial
Jun 04, 2018
Cantex Pharmaceuticals, Inc. Announces That Clinical Trial Data For CX-01 In Refractory Acute Myeloid Leukemia And Myelodysplastic Syndrome Will Be Presented At The 2018 ASCO Annual Meeting
Apr 16, 2018
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago
Jan 11, 2018
Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML)
Sep 05, 2017
MEI Pharma Reports Fiscal Year 2017 Results
Jun 05, 2017
Helsinn Group and MEI Pharma Report Correlation between Mutations in DNA Methylation Pathway and Clinical Response in Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Latest News
Dec 8, 2023
Safran and Egyptian Air Force sign MoU for EngineLife® services
Dec 8, 2023
Italian Air Force Flies New MQ-9A Block 5 RPA from GA-ASI
Dec 8, 2023
Damen Naval marks official start of construction phase F126 frigates
Dec 8, 2023
KNDS commissioned to supply 50 Dingo 2 vehicles to the Bundeswehr
Dec 8, 2023
U.S. Marine Corps orders more Amphibious Combat Vehicles from BAE Systems
Dec 8, 2023
Milrem Robotics partners with the Ukrainian Defence Industry to forge next-generation multi-domain robotic...
Dec 8, 2023
Successful Live Fire Demo Clears Path For Spike NLOS Airworthiness Release Onto U.S. Apache
Dec 8, 2023
Elbit America wins $500 Million contract to continue supplying Night Vision to U.S Marines
View all News
Agenda
23
April
Denmark
Scandic Sluseholmen, Copenhagen, Denmark
Arctic Security conference, 23 - 24 April 2024, Scandic Sluseholmen, Copenhagen, Denmark
Defence iQ are proud to present Arctic Security conference taking place on 23 - 24 April, 2024 at Scandic Sluseholmen,...
13
March
Copthorne Tara, London, UK
Deployed Medical Healthcare Delivery, 13 - 14 March 2024, Copthorne Tara, London, UK
This two-day event will address military medical capability is increasingly relevant within the context of attritional...
05
March
United States of America
Sheraton Austin Hotel at the Capitol, Austin, Texas
IDGA Future Indirect Fires conference, 5 - 6 March 2024, Sheraton Austin Hotel at the Capitol, Austin, Texas
IDGA are proud to present the return of the Future Indirect Fires conference taking place on March 5-6, 2024 in...
View All Events